Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients

Lignende værker

• The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease
  af: Vezina, Heather E, et al.
  Udgivet: (2009)
• Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir
  af: Perrottet, N., et al.
  Udgivet: (2009)
• Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients
  af: La Rosa, Corinna, et al.
  Udgivet: (2011)
• Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients
  af: Gardiner, Bradley J, et al.
  Udgivet: (2017)
• Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients
  af: Nath, Christa E, et al.
  Udgivet: (2007)